Invesco NASDAQ Future Gen 200 ETF
Portfolio
Holdings
Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACIU.NASDAQ | AC Immune Ltd | USA | Healthcare | Biotechnology | 2024-09-30 | 0.014 | 0.493 | 13.6k | $19.4k | $36.9k |
| |||||||||||||
ADAP.NASDAQ | Adaptimmune Therapeutics Plc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.025 | 0.383 | 63.3k | $19.8k | $37.2k |
| |||||||||||||
AMRN.NASDAQ | Amarin Corporation PLC | USA | Healthcare | Drug Manufacturers - General | 2024-09-30 | 0.017 | 0.379 | 70.6k | $91.3k | $39.1k |
| |||||||||||||
ATOM.NASDAQ | Atomera Inc | USA | Technology | Semiconductor Equipment & Materials | 2024-09-30 | 0.058 | 1.084 | 16.5k | $9.1k | $137.1k |
| |||||||||||||
AUTL.NASDAQ | Autolus Therapeutics Ltd | USA | Healthcare | Biotechnology | 2024-09-30 | 0.006 | 0.791 | 10.4k | $18.7k | $22k |
| |||||||||||||
CGEN.NASDAQ | Compugen | USA | Healthcare | Biotechnology | 2024-09-30 | 0.024 | 0.354 | 21k | $15.4k | $48.4k |
| |||||||||||||
CRVS.NASDAQ | Corvus Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.023 | 0.346 | 10.4k | $1.9k | $53.1k |
| |||||||||||||
DCTH.NASDAQ | Delcath Systems Inc | USA | Healthcare | Medical Devices | 2024-09-30 | 0.02 | 0.619 | 5.5k | $1.3k | $85.3k |
| |||||||||||||
EYEN.NASDAQ | Eyenovia Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.03 | 0.419 | 11.2k | $370.49 | $30k |
| |||||||||||||
FGEN.NASDAQ | FibroGen Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.12 | 0.544 | 120.9k | -$242k | $57.5k |
| |||||||||||||
GRTX.NASDAQ | GRTX.NASDAQ | - | - | - | - | 0.29 | 0.398 | 157.6k | - | - | ||||||||||||||
IFRX.NASDAQ | InflaRx N.V. | USA | Healthcare | Biotechnology | 2024-09-30 | 0.014 | 0.2 | 8.3k | $9.6k | $20.2k |
| |||||||||||||
IMAB.NASDAQ | I-Mab | USA | Healthcare | Biotechnology | 2024-09-30 | 0.029 | 0.497 | 23.2k | $66.2k | $22.1k |
| |||||||||||||
IMUX.NASDAQ | Immunic Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.041 | 0.413 | 36.8k | $14.9k | $35.5k |
| |||||||||||||
MVST.NASDAQ | Microvast Holdings Inc | USA | Industrials | Electrical Equipment & Parts | 2024-09-30 | 0.048 | 1.235 | 153.4k | $212.9k | $240.9k |
| |||||||||||||
NEON.NASDAQ | Neonode Inc | USA | Technology | Electronic Components | 2024-09-30 | 0.033 | 0.514 | 5.5k | $6.2k | $48.9k |
| |||||||||||||
ORMP.NASDAQ | Oramed Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.025 | 0.397 | 10k | $38.3k | $21.8k |
| |||||||||||||
PDSB.NASDAQ | PDS Biotechnology Corp | USA | Healthcare | Biotechnology | 2024-09-30 | 0.037 | 0.32 | 13.8k | $8.1k | $21.9k |
| |||||||||||||
PRQR.NASDAQ | ProQR Therapeutics BV | USA | Healthcare | Biotechnology | 2024-09-30 | 0.011 | 0.353 | 11.8k | $2.9k | $26.7k |
| |||||||||||||
VRCA.NASDAQ | Verrica Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.039 | 0.28 | 35.6k | -$13.4k | $23.8k |
|
Trades
Adds
Report date: 2023-06-29
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ADAP.NASDAQ | 1.3k | 4.3 | 1.6k | 1-2 | $0.59 | -33.3% |
AUTL.NASDAQ | 446.00 | 4.4 | 1k | 2-3 | $2.11 | 31.1% |
IFRX.NASDAQ | 331.00 | 4.4 | 1.4k | 2-7 | $2.41 | 35.4% |
ORMP.NASDAQ | 343.00 | 4.3 | 1k | 2-5 | $2.16 | 3.3% |
PRQR.NASDAQ | 797.00 | 4.3 | 1.5k | 2-3 | $2.25 | 42.4% |
Report date: 2023-06-22
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ADAP.NASDAQ | 1.3k | 4.5 | 1.6k | 1-2 | $0.59 | -35.4% |
AUTL.NASDAQ | 446.00 | 4.5 | 1k | 2-3 | $2.11 | 31.1% |
CRVS.NASDAQ | 456.00 | 4.5 | 864.13 | 1-4 | $5.07 | 735.3% |
EYEN.NASDAQ | 488.00 | 4.5 | 1.7k | 2-6 | $2.68 | 10.7% |
IFRX.NASDAQ | 331.00 | 4.5 | 1.3k | 2-7 | $2.41 | 39.3% |
ORMP.NASDAQ | 343.00 | 4.5 | 1k | 2-5 | $2.16 | 3.3% |
PRQR.NASDAQ | 797.00 | 4.5 | 1.6k | 2-4 | $2.25 | 38.9% |
Comments
How you think about this?